Clinical Trial Update: Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites [Phase 4]

View source ↗

Summary

This report provides an update on a Phase 4 trial evaluating house dust mite sublingual immunotherapy in children with asthma or allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• House Dust Mite Sublingual Immunotherapy (Sublingual immunotherapy extract for dust mite)

Snippet

Sponsor: Medical University of Lodz | Conditions: Bronchial Asthma, Allergic Rhinitis | Phase 4 | Status: UNKNOWN